Acquired resistance to irradiation or docetaxel is not associated with cross-resistance to cisplatin in prostate cancer cell lines

被引:0
作者
Lukas Donix
Holger H. H. Erb
Claudia Peitzsch
Anna Dubrovska
Manuel Pfeifer
Christian Thomas
Susanne Fuessel
Kati Erdmann
机构
[1] Technische Universität Dresden,Department of Urology, Faculty of Medicine
[2] National Center for Tumor Diseases (NCT),National Center for Radiation Research in Oncology (OncoRay), Faculty of Medicine
[3] Dresden,Helmholtz
[4] Germany: German Cancer Research Center (DKFZ),Zentrum Dresden
[5] Heidelberg,Rossendorf
[6] Germany; Faculty of Medicine and University Hospital Carl Gustav Carus,Institute of Legal Medicine, Faculty of Medicine
[7] Technische Universität Dresden,undefined
[8] Dresden,undefined
[9] Germany; Helmholtz-Zentrum Dresden-Rossendorf (HZDR),undefined
[10] Technische Universität Dresden,undefined
[11] Institute of Radiooncology - OncoRay,undefined
[12] German Cancer Consortium (DKTK),undefined
[13] Partner Site Dresden,undefined
[14] Dresden and German Cancer Research Center (DKFZ),undefined
[15] Technische Universität Dresden,undefined
来源
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词
Cisplatin; Docetaxel; mCRPC; NEPC; Prostate cancer; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1313 / 1324
页数:11
相关论文
共 50 条
  • [21] Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines
    Januchowski, Radoslaw
    Sterzynska, Karolina
    Zaorska, Katarzyna
    Sosinska, Patrycja
    Klejewski, Andrzej
    Brazert, Maciej
    Nowicki, Michal
    Zabel, Maciej
    JOURNAL OF OVARIAN RESEARCH, 2016, 9 : 1 - 11
  • [22] Targeting the Androgen Receptor Confers In Vivo Cross-resistance Between Enzalutamide and Docetaxel, But Not Cabazitaxel, in Castration-resistant Prostate Cancer
    van Soest, Robert J.
    de Morree, Ellen S.
    Kweldam, Charlotte F.
    de Ridder, Corrina M. A.
    Wiemer, Erik A. C.
    Mathijssen, Ron H. J.
    de Wit, Ronald
    van Weerden, Wytske M.
    EUROPEAN UROLOGY, 2015, 67 (06) : 981 - 985
  • [23] KIFC1 induces resistance to docetaxel and is associated with survival of patients with prostate cancer
    Sekino, Yohei
    Oue, Naohide
    Shigematsu, Yoshinori
    Ishikawa, Akira
    Sakamoto, Naoya
    Sentani, Kazuhiro
    Teishima, Jun
    Matsubara, Akio
    Yasui, Wataru
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (01) : 31.e13 - 31.e20
  • [24] Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines
    Zejia Yang
    Patrick J. Faustino
    Paul A. Andrews
    Rachelle Monastra
    Audrey A. Rasmussen
    Christopher D. Ellison
    Kevin J. Cullen
    Cancer Chemotherapy and Pharmacology, 2000, 46 : 255 - 262
  • [25] Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines
    Yang, ZJ
    Faustino, PJ
    Andrews, PA
    Monastra, R
    Rasmussen, AA
    Ellison, CD
    Cullen, KJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2000, 46 (04) : 255 - 262
  • [26] The Involvement of Mitochondrial Membrane Potential in Cross-Resistance Between Radiation and Docetaxel
    Kuwahara, Yoshikazu
    Roudkenar, Mehryar Habibi
    Suzuki, Masatoshi
    Urushihara, Yusuke
    Fukumoto, Motoi
    Saito, Yohei
    Fukumoto, Manabu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (03): : 556 - 565
  • [27] GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
    Styliani Karanika
    Theodoros Karantanos
    Shinji Kurosaka
    Jianxiang Wang
    Takahiro Hirayama
    Guang Yang
    Sanghee Park
    Alexei A. Golstov
    Ryuta Tanimoto
    Likun Li
    Timothy C. Thompson
    Molecular Cancer, 14
  • [28] Time to Castration Resistance as a Predictor of Response to Docetaxel in Metastatic Castration Resistance in Prostate Cancer
    Gulturk, Ilkay
    Erdal, Gulcin Sahingoz
    Sonmezoz, Gulru Birce
    Yilmaz, Mesut
    Tacar, Seher Yildiz
    Ozmen, Aykut
    Ozyukseler, Deniz Tataroglu
    Dulgar, Ozgecan
    Cil, Ibrahim
    Tural, Deniz
    ISTANBUL MEDICAL JOURNAL, 2022, 23 (04): : 269 - 274
  • [29] Cross-Resistance to Abiraterone and Enzalutamide in Castration Resistance Prostate Cancer Cellular Models Is Mediated by AR Transcriptional Reactivation
    Simon, Iris
    Perales, Sonia
    Casado-Medina, Laura
    Rodriguez-Martinez, Alba
    del Carmen Garrido-Navas, Maria
    Puche-Sanz, Ignacio
    Diaz-Mochon, Juan J.
    Alaminos, Clara
    Lupianez, Pablo
    Lorente, Jose A.
    Serrano, Maria J.
    Real, Pedro J.
    CANCERS, 2021, 13 (06) : 1 - 21
  • [30] GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells
    Karanika, Styliani
    Karantanos, Theodoros
    Kurosaka, Shinji
    Wang, Jianxiang
    Hirayama, Takahiro
    Yang, Guang
    Park, Sanghee
    Golstov, Alexei A.
    Tanimoto, Ryuta
    Li, Likun
    Thompson, Timothy C.
    MOLECULAR CANCER, 2015, 14